CLPTM1L Antikörper (AA 150-200)
-
- Target Alle CLPTM1L Antikörper anzeigen
- CLPTM1L (CLPTM1-Like (CLPTM1L))
-
Bindungsspezifität
- AA 150-200
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CLPTM1L Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunoprecipitation (IP)
- Verwendungszweck
- Rabbit anti-CLPTM1L Antibody, Affinity Purified
- Homologie
- Orangutan
- Aufreinigung
- Affinity Purified
- Immunogen
- between AA 150 and 200
- Isotyp
- IgG
- Top Product
- Discover our top product CLPTM1L Primärantikörper
-
-
- Applikationshinweise
-
IP: 50-100 μL/mg lysate
WB: 1:10,000 - 1:25,000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1000 μg/mL
- Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Haltbarkeit
- 12 months
-
- Target
- CLPTM1L (CLPTM1-Like (CLPTM1L))
- Andere Bezeichnung
- CLPTM1L (CLPTM1L Produkte)
- Synonyme
- CRR9 antikoerper, C130052I12Rik antikoerper, Crr9 antikoerper, RGD1307896 antikoerper, C130052I12RIK antikoerper, CLPTM1 like antikoerper, CLPTM1-like antikoerper, cleft lip and palate transmembrane protein 1-like protein antikoerper, CLPTM1L antikoerper, clptm1l antikoerper, LOC100338302 antikoerper, Clptm1l antikoerper
- Hintergrund
- Background: CLPTM1L is a membrane protein whose overexpression in cisplatin-sensitive cells causes apoptosis. Polymorphisms in its coding sequence have been reported to increase susceptibility to several cancers, including lung, pancreatic, and breast cancers. [provided by RefSeq, Nov 2015] [taken from NCBI Entrez Gene (Gene ID: 81037)].
- Gen-ID
- 81037
- UniProt
- Q96KA5
-